LU82345A1 - Methode de detection du cancer - Google Patents
Methode de detection du cancer Download PDFInfo
- Publication number
- LU82345A1 LU82345A1 LU82345A LU82345A LU82345A1 LU 82345 A1 LU82345 A1 LU 82345A1 LU 82345 A LU82345 A LU 82345A LU 82345 A LU82345 A LU 82345A LU 82345 A1 LU82345 A1 LU 82345A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- cancer
- concentration
- dna
- protein
- bleomycin
- Prior art date
Links
Classifications
-
- G01N33/5755—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G01N33/57585—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4704—Inhibitors; Supressors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/50—Fibroblast growth factors [FGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Sink And Installation For Waste Water (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2873279A | 1979-04-10 | 1979-04-10 | |
| US2873279 | 1979-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU82345A1 true LU82345A1 (fr) | 1980-12-16 |
Family
ID=21845111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU82345A LU82345A1 (fr) | 1979-04-10 | 1980-04-08 | Methode de detection du cancer |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS55143441A (es) |
| KR (1) | KR830002502A (es) |
| AR (1) | AR222700A1 (es) |
| AT (1) | AT365343B (es) |
| AU (1) | AU536522B2 (es) |
| BE (1) | BE882669A (es) |
| CH (1) | CH644453A5 (es) |
| DE (1) | DE3013837A1 (es) |
| DK (1) | DK149980A (es) |
| ES (1) | ES8103380A1 (es) |
| FI (1) | FI801078A7 (es) |
| FR (1) | FR2454099A1 (es) |
| GB (1) | GB2047712B (es) |
| GR (1) | GR67692B (es) |
| HU (1) | HU183122B (es) |
| IE (1) | IE49981B1 (es) |
| IL (1) | IL59772A (es) |
| IT (1) | IT1143135B (es) |
| LU (1) | LU82345A1 (es) |
| NL (1) | NL8002094A (es) |
| NO (1) | NO801018L (es) |
| PH (1) | PH15637A (es) |
| SE (1) | SE8002602L (es) |
| ZA (1) | ZA802141B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3524644A1 (de) * | 1985-07-10 | 1987-01-15 | Heyl Chem Pharm | Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung |
-
1980
- 1980-03-28 PH PH23825A patent/PH15637A/en unknown
- 1980-04-03 IE IE693/80A patent/IE49981B1/en unknown
- 1980-04-03 AU AU57193/80A patent/AU536522B2/en not_active Ceased
- 1980-04-03 FI FI801078A patent/FI801078A7/fi not_active Application Discontinuation
- 1980-04-03 SE SE8002602A patent/SE8002602L/ not_active Application Discontinuation
- 1980-04-04 BE BE0/200139A patent/BE882669A/fr not_active IP Right Cessation
- 1980-04-04 FR FR8007691A patent/FR2454099A1/fr active Granted
- 1980-04-04 IL IL59772A patent/IL59772A/xx unknown
- 1980-04-07 JP JP4475080A patent/JPS55143441A/ja active Pending
- 1980-04-08 DK DK149980A patent/DK149980A/da not_active IP Right Cessation
- 1980-04-08 LU LU82345A patent/LU82345A1/fr unknown
- 1980-04-09 ES ES490396A patent/ES8103380A1/es not_active Expired
- 1980-04-09 NO NO801018A patent/NO801018L/no unknown
- 1980-04-09 IT IT48370/80A patent/IT1143135B/it active
- 1980-04-09 NL NL8002094A patent/NL8002094A/nl not_active Application Discontinuation
- 1980-04-10 CH CH277880A patent/CH644453A5/fr not_active IP Right Cessation
- 1980-04-10 AR AR280624A patent/AR222700A1/es active
- 1980-04-10 AT AT0195780A patent/AT365343B/de not_active IP Right Cessation
- 1980-04-10 DE DE19803013837 patent/DE3013837A1/de not_active Withdrawn
- 1980-04-10 ZA ZA00802141A patent/ZA802141B/xx unknown
- 1980-04-10 KR KR1019800001518A patent/KR830002502A/ko not_active Ceased
- 1980-04-10 HU HU80871A patent/HU183122B/hu unknown
- 1980-04-10 GB GB8011902A patent/GB2047712B/en not_active Expired
- 1980-04-10 GR GR61652A patent/GR67692B/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI801078A7 (fi) | 1981-01-01 |
| IE800693L (en) | 1980-10-10 |
| GB2047712B (en) | 1983-02-23 |
| HU183122B (en) | 1984-04-28 |
| IL59772A0 (en) | 1980-06-30 |
| FR2454099A1 (fr) | 1980-11-07 |
| NL8002094A (nl) | 1980-10-14 |
| KR830002502A (ko) | 1983-05-30 |
| IL59772A (en) | 1983-05-15 |
| SE8002602L (sv) | 1980-12-09 |
| DK149980A (da) | 1980-10-11 |
| GR67692B (es) | 1981-09-07 |
| PH15637A (en) | 1983-03-11 |
| ATA195780A (de) | 1981-05-15 |
| NO801018L (no) | 1980-10-13 |
| AR222700A1 (es) | 1981-06-15 |
| IT1143135B (it) | 1986-10-22 |
| DE3013837A1 (de) | 1980-10-30 |
| IE49981B1 (en) | 1986-01-22 |
| AT365343B (de) | 1982-01-11 |
| CH644453A5 (fr) | 1984-07-31 |
| AU5719380A (en) | 1980-10-16 |
| GB2047712A (en) | 1980-12-03 |
| AU536522B2 (en) | 1984-05-10 |
| BE882669A (fr) | 1980-10-06 |
| ZA802141B (en) | 1981-04-29 |
| IT8048370A0 (it) | 1980-04-09 |
| FR2454099B1 (es) | 1984-01-27 |
| ES490396A0 (es) | 1981-02-16 |
| ES8103380A1 (es) | 1981-02-16 |
| JPS55143441A (en) | 1980-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Musante et al. | A simplified method to recover urinary vesicles for clinical applications and sample banking | |
| ES2346467T3 (es) | Marcadores neurodegenerativos para la depresion. | |
| Baldini et al. | Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome? | |
| FR2461256A1 (fr) | Procede et necessaire de diagnostic du cancer par determination des liaisons glucosidiques associees aux tumeurs | |
| WO2010012306A1 (en) | Healthy kidney biomarkers | |
| Motomiya et al. | Circulating level of α2-macroglobulin–β2-microglobulin complex in hemodialysis patients | |
| US4270924A (en) | Diagnostic method for detecting cancer | |
| Hamad et al. | Assessment the role of kidney function and total proteins in patients with diabetic nephropathy in Kirkuk city/Iraq | |
| Schwartz et al. | Quantitative assay of erythrocyte “free” and zinc-protoporphyrin: Clinical and genetic studies | |
| de Jong et al. | Sample collection and handling considerations for peptidomic studies in whole saliva; implications for biomarker discovery | |
| Bootorabi et al. | Modification of carbonic anhydrase II with acetaldehyde, the first metabolite of ethanol, leads to decreased enzyme activity | |
| LU82345A1 (fr) | Methode de detection du cancer | |
| Xiang et al. | Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection. | |
| Mirza et al. | Label-free quantitation of the changes in salivary proteome associated with the chronic consumption of the betel nut (Areca catechu) | |
| KR102475926B1 (ko) | 전신 홍반성 루푸스 진단용 바이오마커 조성물 및 이를 이용한 전신 홍반성 루푸스 진단에 필요한 정보를 제공하는 방법 | |
| Bąchor et al. | Identyfication of tryptic podocin peptide in the feline urine sediments using LC-MS/MRM method | |
| Kȩdziora‐Kornatowska et al. | Effects of perindopril and hydrochlorothiazide on selected indices of oxidative stress in the blood of elderly patients with essential hypertension | |
| RU2296992C1 (ru) | Способ определения состояния мембран эритроцитов | |
| KR102497196B1 (ko) | 전립선암 진단 점수 계산 방법 및 그 용도 | |
| US5804368A (en) | Method for screening for prostate cancer by measuring apolipoprotein D levels in body fluid | |
| WO2023143650A1 (en) | Method for determination of mutated form of mucin-1 protein in a biological sample | |
| CN102481320A (zh) | 在糖尿病前期和2型糖尿病中血清淀粉样蛋白的表型比例 | |
| JPH02293665A (ja) | 腎疾患の検査方法 | |
| JP2573189B2 (ja) | カリクレインの検出方法 | |
| Aiken et al. | Characteristic visible fluorescence emission spectra of sera from cancer patients |